Finch Therapeutics Group, Inc.
OTC: FNCH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Matthew Blischak
- Employees
- 1
- Headquarters
- Boston, United States
- IPO year
- 2021
- Market cap
- $14.0M
- Website
- https://www.finchtherapeutics.com
Loading FNCH…
Loading profile data…Frequently asked questions about FNCH
What does Finch Therapeutics Group, Inc. (FNCH) do?
Finch Therapeutics is a microbiome technology company with a portfolio of intellectual property and microbiome assets. The company is now focused on realizing the value of its intellectual property estate and other assets, while supporting the advancement of its microbiome technology through partnerships and collaborations after winding down dev...
Where does FNCH trade?
Finch Therapeutics Group, Inc. (FNCH) trades on the Other OTC.
What sector is FNCH in?
Finch Therapeutics Group, Inc. (FNCH) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Finch Therapeutics Group, Inc.?
Matthew Blischak is the chief executive officer of Finch Therapeutics Group, Inc. (FNCH).
Where is Finch Therapeutics Group, Inc. headquartered?
Finch Therapeutics Group, Inc. is headquartered in United States.
Does FNCH pay a dividend?
Finch Therapeutics Group, Inc. (FNCH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did FNCH go public?
Finch Therapeutics Group, Inc. (FNCH) completed its initial public offering in 2021.